enzastaurin has been researched along with Carcinoma, Epidermoid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boehm, A; Dietz, A; Giannis, A; Mozet, C; Wichmann, G | 1 |
| Barata, F; Barlesi, F; Bearz, A; Bepler, G; Chiappori, A; Chouaki, N; Iscoe, N; Liepa, AM; Park, K; Reck, M; Scagliotti, G; Soria, JC; von Pawel, J; Wagle, A; Zhao, YD | 1 |
| Cohen, EE; Kuo, WL; Liu, J; Mauceri, H; Rosner, MR; Vokes, EE; Weichselbaum, R | 1 |
| Hayes, DN; Shores, CG; Yin, X | 1 |
| Ciaccio, MF; Cohen, EE; Jones, RB; Kuo, WL; Lingen, M; Liu, J; Rosner, MR; Seiwert, TY | 1 |
1 review(s) available for enzastaurin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Current aspects of targeted therapy in head and neck tumors.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; ErbB Receptors; Folic Acid Antagonists; Glutamates; Guanine; Head and Neck Neoplasms; Humans; Indoles; Pemetrexed; Protein-Tyrosine Kinases | 2008 |
1 trial(s) available for enzastaurin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Phase II, double-blinded, randomized study of enzastaurin plus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Double-Blind Method; Female; Folic Acid; Glutamates; Guanine; Humans; Indoles; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Pemetrexed; Prognosis; Salvage Therapy; Survival Rate; Vitamin B 12 | 2010 |
3 other study(ies) available for enzastaurin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.
Topics: Animals; Base Sequence; Carcinoma, Squamous Cell; Cell Cycle; Cell Line; Cell Proliferation; Cyclin D1; DNA Primers; Female; Head and Neck Neoplasms; Humans; Indoles; Mice; Mice, Nude; Oligonucleotide Array Sequence Analysis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction; Transplantation, Heterologous | 2010 |
Antitumor activity of enzastaurin as radiation sensitizer in head and neck squamous cell carcinoma.
Topics: Animals; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Death; Cell Line, Tumor; Disease Models, Animal; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Immunohistochemistry; Indoles; Mice; Mice, Nude; Neovascularization, Pathologic; Protein Kinase C; Protein Kinase C beta; Radiation-Sensitizing Agents; Random Allocation; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays | 2011 |
Effect of complementary pathway blockade on efficacy of combination enzastaurin and rapamycin.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Female; Head and Neck Neoplasms; In Situ Nick-End Labeling; Indoles; MAP Kinase Signaling System; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Protein Kinase Inhibitors; Sirolimus; Squamous Cell Carcinoma of Head and Neck; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2011 |